TABLE IV.
Multivariate Analysis of HLA Alloimmunization in SCD
| Variable | Odds ratio | Wald 95% CI | P-value |
|---|---|---|---|
| RBC antibodies | 3.61 | (1.05–12.3) | 0.041 |
| Age ≥13 | 3.08 | (0.69–13.8) | 0.14 |
| Lifetime number of RBC unitsa | |||
| 25–49 | 0.85 | (0.05–15.5) | 0.91 |
| 50–99 | 8.13 | (0.92–72.2) | 0.06 |
| ≥100 | 2.78 | (0.20–38.0) | 0.44 |
| Chronic transfusion therapyb | |||
| Current | 0.52 | (0.04–6.91) | 0.62 |
| Past | 0.35 | (0.03–3.97) | 0.39 |
| LR historyc | |||
| Not exclusively LR | 0.81 | (0.15–4.40) | 0.81 |
| Incomplete LR history | 1.78 | (0.28–11.4) | 0.54 |
| Days since last RBC transfusion | 1.00 | (0.999–1.002) | 0.63 |
| Splenectomy | 0.25 | (0.04–1.57) | 0.14 |
LR, leukoreduction. Odds ratios (95% confidence intervals) for each predictor variable are shown.
Reference group: <25 units;
Reference group: never received chronic transfusion therapy;
Reference group: exclusively LR units.